Apollo Hospitals Stock: HealthCo Demerger and 1,500-Bed Expansion Drive Multi-Year Growth
Strong Q3 performance and strategic restructuring push brokerages to maintain buy ratings with 20% upside as hospital margins hit 24.8% […]
Strong Q3 performance and strategic restructuring push brokerages to maintain buy ratings with 20% upside as hospital margins hit 24.8% […]
Infosys tells investors exactly how it plans to win the AI era – and analysts reckon the upside case is
Torrent Pharma delivered a textbook quarter — revenues up 18 per cent year-on-year to Rs 33 billion, profits climbing 26
A GST-driven margin surprise and accelerating sales has brokerages agree the growth story has legs Britannia Industries is back in
Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls IPCA Laboratories has emerged as
With Nifty IT down 15% in a month and FCF yields at crisis levels, analysts ask: Is this a Kodak
A 50% revenue surge and 400% profit jump have made analysts sit up and take notice When a mid-cap jewellery
Lupin has delivered the goods this quarter. When a pharmaceutical company beats estimates across revenue, margins, and profit in a
Uttar Pradesh is rolling out the welcome mat for alcohol manufacturers, and it could change the fortunes of two home
There is a particular kind of market injustice reserved for companies that do everything right at the wrong time.